Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Motor Activity 2 Lymphoma 2 Colorectal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Neoplasms 1 Medical Oncology 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Fasting 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Anastomotic Leak 1

Interventions

Cyclophosphamide 7 acalabrutinib 4 pirtobrutinib 3 fludarabine 3 Rituximab 3 fludarabine phosphate 2 Vincristine 2 Melphalan 2 Doxorubicin 2 thymoglobulin 1 obinutuzumab 1 idecabtagene vicleucel 1 ibrutinib 1 Stem Cell Transplantation 1 Prednisone 1 Prednisolone 1 Mycophenolic Acid 1 Mesna 1 Immunotherapy, Adoptive 1 Filgrastim 1 Diet 1 Bone Marrow Transplantation 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Leukemia, B-Cell × Diet × Clear all

NCT07487428 2026-03-23

CLL-IMPACT

Technical University of Munich

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡